Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • Lowering blood sugar...

    Lowering blood sugar and BP reduces CVD risk in young diabetics

    Written by Medha Baranwal Baranwal Published On 2019-06-17T19:05:06+05:30  |  Updated On 17 Jun 2019 7:05 PM IST
    Lowering blood sugar and BP reduces CVD risk in young diabetics
    Lowering blood sugar and BP reduces CVD risk in young diabetics, finds a new study.

    In young adults with type 1 diabetes (T1D), high blood sugar levels and high blood pressure (BP) pose a similar cardiovascular threat.


    Findings of the study, published in the ADA journal Diabetes, support that lower BP goals (i.e., 120/80 mmHg) than 2018 ADA recommendations (140/90 mmHg) may be needed for young adults with T1D. In addition to maintaining good blood sugar control, lowering the BP may also further reduce cardiovascular risk in these individuals.


    The findings were also presented at the 79th Scientific Sessions of the American Diabetes Association, held from June 7 – 11, 2019.


    Jingchuan Guo, MD, PhD, of the University of Pittsburgh, Pennsylvania, and colleagues conducted the study to determine optimal BP goals for minimizing the risk of coronary artery disease (CAD) in adults with childhood-onset type 1 diabetes.


    When HbA1c levels are very high, the primary treatment focus in patients with type 1 diabetes should be on blood sugar control, according to Dr Guo. However, when HbA1c levels are within the normal range, the focus on blood pressure becomes increasingly critical.


    For the study, the researchers recruited a total of 605 participants without known baseline coronary artery disease and followed them for 25 years. Enrolled patients had been diagnosed with type 1 diabetes at age 17 years or younger.


    The novel aspect of the study was that time-weighted blood pressure measurements were created to reflect long-term exposure to blood pressure comprehensively. A dose-gradient association was observed between time-weighted systolic and diastolic blood pressure levels, along with mean arterial pressure, and risk of coronary artery disease.

    Also Read: Semaglutide reduces cardiac events in high risk diabetics: PIONEER 6 trial

    Key findings of the study include:

    • Optimal (in terms of lower risk of coronary artery disease) levels for systolic blood pressure, diastolic blood pressure, and mean arterial pressure were approximately 120, 80, and 90 mm Hg, respectively.

    • Participants with blood pressure levels ≥120/80 mm Hg, vs <120/80 mm Hg, were at a twofold increased risk of developing coronary artery disease.

    • When participants were stratified into four categories by time-weighted blood pressure (lower than 120/80 mm Hg or greater) and time-weighted HbA1c (lower than 8% or greater) vs participants who met targets for both blood pressure (<120/80 mm Hg) and HbA1c (<8%), the high blood pressure-only group were at similar risk vs the high HbA1c-only group.


    Also Read: Intensive blood sugar lowering of no benefit in type 2 diabetes patients, reveals 15-year long study

    Dr Guo concluded that the findings supported the possible benefit of optimal blood pressure goals lower than the current recommendations of 140/90 mmHg to reduce cardiovascular risk among young adults with type 1 diabetes.


    Lowering blood pressure and blood sugar and meeting glycemic targets may further reduce cardiovascular risk in these individuals, improving long-term outcomes and reducing additional serious complications of type 1 diabetes.


    For detailed study log on to https://doi.org/10.2337/db19-1464-P
    blood pressureblood sugarblood sugar testBPcardiovascular diseaseCardiovascular Riskchildhood onset type 1 diabetesCoronary artery diseaseCVDCVD Riskdiabetesdiabetes insipidusDiabetes journalDiabetes Mellitusdiabetes symptomsFasting blood sugargestational diabetesglycemic targetsHbA1cHeart diseaseinsulininsulin dosageinsulin injection sitesJingchuan Guolower blood pressurelower BPnormal blood sugarnormal blood sugar leveloptimal blood pressuretype 1 diabetes symptomstype 2 dia

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok